Search clinical trials for: DA-2803-R

Total 2396 results

1
2
3
4
5
6
7
8
9
10
...
47
48
›

Dong-A ST Co., Ltd.

Completed

Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B Patients

Hepatitis B

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-R

Healthy Adult Participants
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State

Healthy

South Korea
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State

Healthy

South Korea
Dong-A ST Co., Ltd.

Completed

A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult Subjects

Healthy Adult

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy Subjects

Hepatitis B

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult Subjects

Infective Disorder

South Korea
Dong-A ST Co., Ltd.

Recruiting

A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evaluate the Food Effect on DA-5216.

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Clinical Trial of DA-5212 in Patients with Functional Dyspepsia

Functional Dyspepsia

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab"

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Recruiting

A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects

Healthy Adult

South Korea
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed State

Healthy

Korea, Republic of
NVP Healthcare

Completed

To Evaluate the Safety and the Pharmacokinetics of NVP-2203

Healthy Volunteers

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fed State

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State

Healthy

Korea, Republic of
University of Utah
ImmunityBio, Inc.

Withdrawn

N-803 Maintenance Therapy Post CAR T-cell Therapy in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas (CARMEN-803)

B-cell Non Hodgkin Lymphoma

United States
Dong-A Pharmaceutical Co., Ltd.

Completed

A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803

Infertility | Induction of Ovulation
Dana-Farber Cancer Institute
Genentech, Inc.

Active, not recruiting

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome

Richter Syndrome

United States
Nordic Lymphoma Group
Helsinki University Central Hospital; Aarhus University Hospital

Active, not recruiting

Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis (Bio-CHIC)

Lymphoma, Large B-Cell, Diffuse

Norway, Denmark, Sweden, Finland
Shandong Provincial Hospital

Recruiting

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Mantle Cell Lymphoma | Diffuse Large B-cell Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | B-cell NonHodgkin Lymphoma

China
Georgetown University
National Cancer Institute (NCI); National Human Genome Research Institute (NHGRI)

Completed

Decision Support Following Genetic Testing for Breast-Ovarian Cancer Susceptibility

Breast Cancer | Ovarian Cancer

United States
Elena N.Parovichnikova

Recruiting

R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)

Lymphoma, High-Grade

Russian Federation
Dong-A ST Co., Ltd.

Not yet recruiting

Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State

Healthy

South Korea
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers

Healthy

Korea, Republic of
Applied Biology, Inc.
Follea International Limited; Daniel Alain, Inc.

Not yet recruiting

Pharmacokinetic Study of DA-020

Chemotherapy Side Effects | Chemotherapy Induced Alopecia

Italy, Brazil
Shin Poong Pharmaceutical Co. Ltd.

Recruiting

Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care (SP-8203-3001)

Ischemic Stroke

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Diabete Mellitus

South Korea
Myung-gui Choi
Dong-A Pharmaceutical Co., Ltd.

Completed

Study on the Effects of DA-9701 on Gastrointestinal Motility on Healthy Adult Volunteers

Healthy Volunteers

Korea, Republic of
NeuroBo Pharmaceuticals Inc.
Dong-A ST Co., Ltd.

Completed

Study of DA-9801 to Treat Diabetic Neuropathy

Diabetic Neuropathy

United States
Dong-A ST Co., Ltd.

Completed

Study of DA-9801 to Treat Diabetic Neuropathic Pain

Diabetic Neuropathies

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult Volunteers

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Withdrawn

A Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects

Healthy Adult

South Korea
Chendu DIAO Pharmaceutical Group CO., LTD.

Completed

Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets (DA168)

Overweight and Obesity

China
Dong-A ST Co., Ltd.

Completed

Phase II Study of DA-6034 Eye Drops in Dry Eye Syndrome (DES)

Dry Eye Syndrome

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Safety and Efficacy of DA-9805 for Parkinson's Disease

Parkinson's Disease

United States
NeuroBo Pharmaceuticals Inc.

Recruiting

First in Human Study in Subjects With Obesity, But Otherwise Healthy

Obesity

United States
Dong-A ST Co., Ltd.

Completed

Phase I Clinical Trial of DA-6886 in Healthy Male Subjects

Irritable Bowel Syndrome

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes

Diabete Mellitus
Applied Biology, Inc.
Follea International Limited; Daniel Alain, Inc.

Not yet recruiting

Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

Chemotherapy Side Effects | Chemotherapy Induced Alopecia

Italy, Brazil
Dong-A ST Co., Ltd.

Completed

A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects

Healthy Adults

Korea, Republic of
Seoul National University Hospital
Samsung Medical Center; Korea University Guro Hospital; Hanyang University; SMG-SNU... and other collaborators

Completed

Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms (PASS-GI)

Dyspepsia | Parkinson Disease

Korea, Republic of
Pharma Power Biotec Co., Ltd.

Unknown

A Study to Evaluate the Efficacy and Safety of PPB-R-203-Based Meal Versus TK9-Based Meal in 20 Patients With Diabetes

Diabetes Mellitus

Taiwan
Dong-A ST Co., Ltd.

Completed

Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male Subjects

Healthy

Korea, Republic of
Chendu DIAO Pharmaceutical Group CO., LTD.

Completed

A Study Evulating DA-302168S Tablets in Overweight/Obese Subjects (DA168)

Overweight and Obesity

China
Pharma Power Biotec Co., Ltd.

Completed

A Study to Evaluate the Blood Glucose Regulation and Safety of PPB-R-203-02 Based Noodle Versus Commercially Available Wet Noodle in Patients With Diabetes

Diabetes Mellitus

Taiwan

1
2
3
4
5
6
7
8
9
10
...
47
48
›

Subscribe